Xylem (XYL) is back in focus after the company announced that Andrea van der Berg will become Chief Financial Officer on September 1, 2026, as part of a broader leadership refresh.

The Xylem share price closed at US$113.42 on the latest trading day and has been under pressure this year, with the year to date share price return down 17.28% and the 1 year total shareholder return down 20.25%. However, the 3 year total shareholder return of 13.75% points to a more constructive longer term picture as investors weigh recent leadership changes, the ongoing dividend and the company’s broader execution record.

Spot fresh ideas around Xylem's leadership reshuffle by comparing it with a hand picked 38 power grid technology and infrastructure stocks that is shaping the future of water, energy and infrastructure.

Xylem now trades at a clear discount to both internal fair value estimates and published analyst targets after a period of weak share price performance and the appointment of a refreshed finance team. The key question for investors is whether this represents a valuation gap or a warning sign reflecting increased caution around the stock.

Most Popular Narrative: 26.3% Undervalued

The most followed narrative currently places Xylem's fair value at $153.88 compared with the last close at $113.42, which leaves a sizeable valuation gap for investors to assess.

Significant and increasing investment in aging water infrastructure (notably in the U.S. and U.K.) underpins a strong multi-year backlog (> $5 billion), with anticipated order rebounds as funding cycles and regulatory timelines normalize, supporting steady revenue growth and greater earnings visibility.

Want to see what sits behind that backlog story and fair value? The narrative focuses on steady revenue build, rising margins and a valuation multiple that needs careful context.

Result: Fair Value of $153.88 (UNDERVALUED)

However, Xylem's narrative is still exposed to delays in government funded water projects and ongoing integration work on recent acquisitions, which could unsettle earnings expectations.

Next Steps

Given the mix of caution and optimism around Xylem, it can be helpful to review the data in detail so you can decide where you stand. To see what investors are currently optimistic about, take a closer look at the 6 key rewards

Looking for more investment ideas beyond Xylem?

If you only focus on Xylem, you could miss other compelling opportunities. Use the Simply Wall St screener to quickly surface stocks that better match your goals.

• Target companies that the market may be overlooking by reviewing a hand picked 20 high quality undiscovered gems before others catch on.
• Strengthen the foundation of your portfolio by scanning a curated list of solid balance sheet and fundamentals (51 results) that can handle tougher conditions.
• Limit unpleasant surprises by focusing on a 75 resilient stocks with low risk scores that screens for resilience and more dependable business profiles.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.